Abstract
Abstract
Introduction
The coronavirus disease (COVID-19) pandemic has changed routine clinical practice worldwide with major impacts on the provision of care and treatment for stroke patients.
Methods
This retrospective observational study included all patients admitted to the Royal Stoke University Hospital in Stoke-on-Trent, UK, with a stroke or transient ischaemic attack between March 15th and April 14th, 2020 (COVID). Patient demographics, characteristics of the stroke, treatment details and logistics were compared with patients admitted in the corresponding weeks in the year before (2019).
Results
There was a 39.5% (n = 101 vs n = 167) reduction in admissions in the COVID cohort compared with 2019 with more severe strokes (median National Institutes of Health Stroke Scale (NIHSS) 7 vs 4, p = 0.02), and fewer strokes with no visible acute pathology (21.8 vs 37.1%, p = 0.01) on computed tomography. There was no statistically significant difference in the rates of thrombolysis (10.9 vs 13.2%, p = 0.72) and/or thrombectomy (5.9 vs 4.8%, p = 0.90) and no statistically significant difference in time from stroke onset to arrival at hospital (734 vs 576 min, p = 0.34), door-to-needle time for thrombolysis (54 vs 64 min, p = 0.43) and door-to-thrombectomy time (181 vs 445 min, p = 0.72). Thirty-day mortality was not significantly higher in the COVID year (10.9 vs 8.9%, p = 0.77). None of the 7 stroke patients infected with COVID-19 died.
Conclusions
During the COVID-19 pandemic, the number of stroke admissions fell, and stroke severity increased. There was no statistically significant change in the delivery of thrombolysis and mechanical thrombectomy and no increase in mortality.
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Neurology (clinical),Dermatology,General Medicine
Reference17 articles.
1. World Health Organisation. Coronavirus disease (COVID-2019) weekly epidemiological update - 21 September 2020. Available on https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports. Accessed 22 Sept 2020
2. Ellul MA, Benjamin L, Singh B, et al. (2020) Neurological associations of COVID-19. Lancet Neurol, Published Online July 2nd, 2020. https://doi.org/10.1016/S1474-4422(20)30221-0
3. Kihira S, Schefflein J, Mahmoudi K et al (2021) Association of coronavirus disease (COVID-19) with large vessel occlusion strokes: a case-control study. AJR 216:1–6. https://doi.org/10.2214/AJR.20.23847
4. Helms J, Kremer S, Merdji H et al (2020) Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. https://doi.org/10.1056/NEJMc2008597
5. Uchino K, Kolikonda MK, Brown D, Kovi S, Collins D, Khawaja Z, Buletko AB, Russman AN, Hussain MS (2020) Decline in stroke presentations during COVID-19 surge. Stroke. 51:00–00. https://doi.org/10.1161/STROKEAHA.120.030331
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献